X-48806405-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2
The NM_006044.4(HDAC6):āc.475A>Cā(p.Met159Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000901 in 1,198,471 control chromosomes in the GnomAD database, including 1 homozygotes. There are 46 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000098 ( 0 hom., 3 hem., cov: 24)
Exomes š: 0.000089 ( 1 hom. 43 hem. )
Consequence
HDAC6
NM_006044.4 missense
NM_006044.4 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 8.02
Genes affected
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), HDAC6. . Gene score misZ 3.2915 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked dominant chondrodysplasia, Chassaing-Lacombe type.
BP4
Computational evidence support a benign effect (MetaRNN=0.09432629).
BP6
Variant X-48806405-A-C is Benign according to our data. Variant chrX-48806405-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 1206265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-48806405-A-C is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HDAC6 | NM_006044.4 | c.475A>C | p.Met159Leu | missense_variant | 7/29 | ENST00000334136.11 | NP_006035.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000981 AC: 11AN: 112149Hom.: 0 Cov.: 24 AF XY: 0.0000874 AC XY: 3AN XY: 34319
GnomAD3 genomes
AF:
AC:
11
AN:
112149
Hom.:
Cov.:
24
AF XY:
AC XY:
3
AN XY:
34319
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000125 AC: 23AN: 183436Hom.: 0 AF XY: 0.000192 AC XY: 13AN XY: 67874
GnomAD3 exomes
AF:
AC:
23
AN:
183436
Hom.:
AF XY:
AC XY:
13
AN XY:
67874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000893 AC: 97AN: 1086268Hom.: 1 Cov.: 26 AF XY: 0.000122 AC XY: 43AN XY: 352650
GnomAD4 exome
AF:
AC:
97
AN:
1086268
Hom.:
Cov.:
26
AF XY:
AC XY:
43
AN XY:
352650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000980 AC: 11AN: 112203Hom.: 0 Cov.: 24 AF XY: 0.0000873 AC XY: 3AN XY: 34383
GnomAD4 genome
AF:
AC:
11
AN:
112203
Hom.:
Cov.:
24
AF XY:
AC XY:
3
AN XY:
34383
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
26
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | HDAC6: BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;T;T;T;T;T;.;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;.;.;.;.;T;T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N;N;N;N;N;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;.;.;.;N;N
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;.;.;.;D;T
Sift4G
Pathogenic
D;D;T;T;T;.;.;.;D;D
Polyphen
0.99
.;.;D;D;D;D;D;.;.;.
Vest4
0.14, 0.24
MutPred
Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);.;Loss of catalytic residue at M159 (P = 0.0867);Loss of catalytic residue at M159 (P = 0.0867);
MVP
MPC
1.5
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at